At a minimum, a good follow-up should include: A clear dose-escalation plan Defined nutrition targets, especially protein Monitoring for known risks A long-term maintenance strategy Bottom line You deserve an evidence-based care plan that is clearly documented and tailored to your health goals
On April 1, 2026, the FDA approved orforglipron (Foundayo) by Eli Lilly for adults with obesity or overweight who also have weight-related medical problems to reduce excess body weight and maintain weight reduction long term, alongside a reduced-calorie diet and increased physical activity
Both Neeland and Ahmed say more research is needed on the health effects from short-term use of GLP-1s.
Lotte Bjerre Knudsen (34:01): Yeah, no, you do not have to be obese
Branded Medications It is important to distinguish between the different formats of semaglutide
Glutathione helps neutralize and clear arsenic out of cells before it can damage other biomolecules